Gleason Score
AgNOR Staining in Prostatic Carcinoma - Comparative study with Bcl-2 and Gleason Score
6
MULTICLASS PATTERN RECOGNITION OF THE GLEASON SCORE OF PROSTATIC CARCINOMAS USING METHODS OF SPATIAL STATISTICS
11
Needle biopsy size and pathological Gleason Score diagnosis: No evidence for a link
5
Original Article Increased expression of EphA1 protein in prostate cancers correlates with high Gleason score
7
Importance and determinants of Gleason score undergrading on biopsy sample of prostate cancer in a population-based study
6
Gleason Score upgrade in prostate cancer patients after radical prostatectomy.
5
<p>Significance of tertiary Gleason pattern 5 in patients with Gleason score 7 after radical prostatectomy: a retrospective cohort study</p>
8
Research Article AgNOR Staining in Prostatic Carcinoma - Comparative Study with p53 and Gleason Score
7
Decreased fucosylated PSA as a urinary marker for high Gleason score prostate cancer
7
Is Small Prostate Volume a Predictor of Gleason Score Upgrading after Radical Prostatectomy?
5
Predictors of Gleason score upgrading in patients with prostate biopsy Gleason score ≤6
5
Epigenetic signature of Gleason score and prostate cancer recurrence after radical prostatectomy
11
Original Article Upgrade in Gleason score between biopsy and radical prostatectomy pathology indicates poor outcomes in prostate cancer
14
Does prostate acinar adenocarcinoma with Gleason Score 3 + 3 = 6 have the potential to metastasize?
5
Stratification of Ki 67 proliferation marker labelling index – Use in Gleason Score Grading of Prostatic Carcinoma
6
Analysis of multiparametric MRI data in prostatic carcinoma- PI-RADS and correlation with gleason score in a 3T MRI
126
PSA density is superior than PSA and Gleason score for adverse
5
Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3?
6
Histological characteristics of the largest and secondary tumors in radical prostatectomy specimens and implications for focal therapy
6
Original Article Nuclear C-MYC expression level is associated with disease progression and potentially predictive of two year overall survival in prostate cancer
11